OncoTrap
Chapel Hill
About OncoTrap
OncoTrap is a biotechnology business that aims to create medications that activate or enhance the immune response to remove tumor burden. The company is working on in vivo nucleic delivery and de novo protein engineering technologies, which will allow healthcare providers to deliver therapeutic genes to tumor sites.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $75.0K
- Last round: Grant (Sep 2022)
- Website: oncotrap.com
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/oncotrap-140638 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.